iGMDRD114
Canonical SMILES: CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O
InChI: InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1
InChI Key: GZOSMCIZMLWJML-VJLLXTKPSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
|---|---|---|---|---|---|
Standard NameAbiraterone CHEMBLCHEMBL254328 Pubchem CID132971 DRUGBANK IDDB05812 Drug StatusAlone Drug TypeSmall Molecule | |||||
Drug Class:
AndrostanesAndrostenesAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsChemically-Induced DisordersCytochrome P-450 CYP1A2 InhibitorsCytochrome P-450 CYP1A2 Inhibitors (strong)Cytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 CYP2C19 Inhibitors (moderate)Cytochrome P-450 CYP2C9 InhibitorsCytochrome P-450 CYP2C9 Inhibitors (moderate)Cytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP2D6 Inhibitors (moderate)Cytochrome P-450 Enzyme InhibitorsCytochrome P450 17A1 InhibitorDrug-Related Side Effects and Adverse ReactionsEndocrine TherapyEnzyme InhibitorsHormone AntagonistsHormone Antagonists and Related AgentsHormones, Hormone Substitutes, and Hormone AntagonistsMetabolic Side Effects of Drugs and SubstancesPolycyclic CompoundsSteroid Synthesis InhibitorsSteroidsDrug Targets:
CYP17A1 (P05093)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot
Models in Abiraterone
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
|---|---|---|---|---|---|---|---|---|
| No matching records found | ||||||||
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.